Literature DB >> 7362773

Mechanisms of C. Parvum-induced coagulopathy in mice.

H D Mitcheson, P Hilgard, A McCraw, J E Castro.   

Abstract

I.v. injection of Corynebacterium parvum (CP) into C57BL and BALB/c mice caused profound coagulation changes, featuring thrombocytopenia, decreased fibrinogen, increased fibrin/fibrinogen degradation products, and a concomitant microangiopathic haemolytic anaemia. These changes were greatest on the 9th day after CP, with recovery by Day 21. I.p. injection caused similar effects but s.c. injection was ineffective. Radiolabelled-platelet kinetics and distribution after i.v. CP indicated disseminated intravascular coagulation with rapid fibrinolysis; EACA treatment exacerbated the thrombosis. The coagulopathy correlated with hepatosplenomegaly, and both were dose dependent. Splenectomy did not effect the coagulopathy, but indomethacin totally abrogated the changes, suggesting that prostaglandin biosynthesis is involved in the pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7362773      PMCID: PMC2010159          DOI: 10.1038/bjc.1980.13

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Increased incidence of lung metastases following treatment of rats bearing hepatomas with irradiated tumour cells and the benefical effect of Corynebacterium parvum in this system.

Authors:  J Proctor; C M Rudenstam; P Alexander
Journal:  Biomedicine       Date:  1973-06-20

2.  Origin and division of liver macrophages during stimulation of the mononuclear phagocyte system.

Authors:  G W Warr; V S Sljivić
Journal:  Cell Tissue Kinet       Date:  1974-11

3.  Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test.

Authors:  J Hawiger; S Niewiarowski; V Gurewich; D P Thomas
Journal:  J Lab Clin Med       Date:  1970-01

4.  Increased phagocytic cell activity and anaemia in Corynebacterium parvum treated mice.

Authors:  W H McBride; J T Jones; D M Weir
Journal:  Br J Exp Pathol       Date:  1974-02

5.  Lympho-reticular stimulatory properties of Corynebacterium parvum and related bacteria.

Authors:  C Adlam; M T Scott
Journal:  J Med Microbiol       Date:  1973-08       Impact factor: 2.472

6.  Adjuvant-induced antired blood cell activity in CBA mice.

Authors:  A McCracken; W H McBride; D M Weir
Journal:  Clin Exp Immunol       Date:  1971-06       Impact factor: 4.330

7.  The production of schistocytes by fibrin strands (a scanning electron microscope study).

Authors:  B S Bull; I N Kuhn
Journal:  Blood       Date:  1970-01       Impact factor: 22.113

8.  Inhibition of tumour growth by administration of killed corynebacterium parvum.

Authors:  B N Halpern; G Biozzi; C Stiffel; D Mouton
Journal:  Nature       Date:  1966-11-19       Impact factor: 49.962

9.  Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts.

Authors:  M F Woodruff; J L Boak
Journal:  Br J Cancer       Date:  1966-06       Impact factor: 7.640

10.  Biological effects of Corynebacterium parvum. 3. Amplification of resistance and impairment of active immunity to murine tumours.

Authors:  S E Smith; M T Scott
Journal:  Br J Cancer       Date:  1972-10       Impact factor: 7.640

View more
  2 in total

1.  Hypercoagulability after immunotherapy with Corynebacterium parvum in man.

Authors:  J Harenberg; A Baumgärtner; D Fritze; R Zimmermann
Journal:  Blut       Date:  1982-04

2.  Platelet activation and aggregation by the opportunistic pathogen Cutibacterium (Propionibacterium) acnes.

Authors:  Frida Petersson; Ola Kilsgård; Oonagh Shannon; Rolf Lood
Journal:  PLoS One       Date:  2018-01-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.